- Record: found
- Abstract: not found
- Article: not found
A new modality for immunosuppression: targeting the JAK/STAT pathway.
2004-06-30
Animals, Enzyme Inhibitors, chemistry, pharmacology, Humans, Immunosuppression, methods, Immunosuppressive Agents, Interleukin Receptor Common gamma Subunit, Janus Kinase 3, Molecular Structure, Mutation, Protein-Tyrosine Kinases, antagonists & inhibitors, genetics, Receptors, Interleukin-7, immunology, Severe Combined Immunodeficiency, drug therapy, enzymology, Signal Transduction, drug effects, Trans-Activators
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Related collections
Author and article information
Animals,Enzyme Inhibitors,chemistry,pharmacology,Humans,Immunosuppression,methods,Immunosuppressive Agents,Interleukin Receptor Common gamma Subunit,Janus Kinase 3,Molecular Structure,Mutation,Protein-Tyrosine Kinases,antagonists & inhibitors,genetics,Receptors, Interleukin-7,immunology,Severe Combined Immunodeficiency,drug therapy,enzymology,Signal Transduction,drug effects,Trans-Activators
Animals, Enzyme Inhibitors, chemistry, pharmacology, Humans, Immunosuppression, methods, Immunosuppressive Agents, Interleukin Receptor Common gamma Subunit, Janus Kinase 3, Molecular Structure, Mutation, Protein-Tyrosine Kinases, antagonists & inhibitors, genetics, Receptors, Interleukin-7, immunology, Severe Combined Immunodeficiency, drug therapy, enzymology, Signal Transduction, drug effects, Trans-Activators